Quest Diagnostics to Expand Blood-Based Colorectal Cancer Screening Access
The company is collaborating with Guardant Health to make Guardant's Shield test available through Quest's nationwide network of provider clients and patient service centers.
Category: Colorectal
Colorectal
Latest
Colorectal
Latest
Colorectal Cancer Screening Rates Improve with Home Testing Kits
Colorectal cancer screening, while highly effective, is underutilized among patients at federally qualified health centers (FQHCs).
Colorectal
Latest
Nationwide Survey Shows Gap in Awareness of Colon Cancer RiskÂ
New research highlights a lack of awareness regarding family history of colorectal cancer, putting many at risk of undiagnosed colon cancer.
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week
Mainz Biomed unveiled findings of the eAArly DETECT study that demonstrated high sensitivity and specificity of their colorectal cancer test.
Read More
FDA Advisory Committee Panel Recommends Approval of Colorectal Blood Test
The FDA’s Medical Devices Advisory Committee recommended approval of Guardant Health’s Shield blood test for colorectal cancer screening.
Read More
Some Patients Repeat Fecal Tests to Delay Colonoscopy
A new study found that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend.
Read More
Choice of Tests Doubled Colorectal Cancer Screening
Offering a choice between colonoscopy and a take-home screening kit more than doubled colorectal cancer screening rates.
Read More
Mainz Biomed Colorectal Cancer Diagnostic Part of FDA Trial
Mainz Biomed N.V. announced results from a clinical study to evaluating integrating its portfolio into its colorectal cancer screening tool.
Read More
Mainz Biomed to Present Results of Colorectal Cancer Screening Study
Mainz Biomed will present the findings of a study that evaluated its multimodal screening test for the detection of colorectal cancer.
Read More
FDA Approves Geneoscopy’s Multi-Target Stool RNA Colorectal Cancer Test
Geneoscopy received U.S. FDA approval for ColoSense, a noninvasive colorectal cancer screening test that uses RNA biomarkers.
Read More
Researchers Identify the Critical Gap in Colorectal Cancer Screening
A significant gap exists in ensuring timely follow-up with colonoscopy after a positive stool test, hindering the effectiveness of screening.
Read More
How Effective are Blood Tests for Colorectal Cancer Screening?
New studies are cautioning against the use of blood tests to replace established colorectal cancer screening tests.
Read More
Next-Gen Stool DNA Test for Colorectal Cancer Has High Detection Rate
Researchers say the test has the best performance for the detection of both colorectal cancer and advanced precancerous polyps.
Read More
Blood Test Shows High Accuracy for Colorectal Cancer Detection
The blood test is intended for screening colorectal cancer in people who are of average risk and not experiencing symptoms.
Read More
Preventive Blood Test for Colorectal Cancer Gets FDA Breakthrough Device Designation
The PreveCol test for cancer is aimed at the early detection of biomarkers in blood associated with colorectal neoplasia.
Read More
Guardant Gives Tentative Date of FDA Advisory Panel Review for Shield Blood Test
Guardant Health announced the FDA is scheduled to review the premarket approval application for the company’s colorectal cancer blood test.
Read More
How At-Home Colorectal Cancer Screenings Pose Challenges
Researchers found that about 10% of at-home screening tests for colorectal cancer tests could not be processed, mostly due to patient error.
Read More
DiaCarta Launches OTC at Home Fecal Occult Blood Test
DiaCarta has received US FDA 510(k) clearance for its over the counter (OTC) at home iColon Fecal Occult Blood Test (FOBT).
Read More